Axsome Therapeutics (AXSM) DMA 50 (2016 - 2026)
Axsome Therapeutics (AXSM) DMA 50 (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
DMA 50 |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
4.18 |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
155.63 |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
4.99 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
25.01 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
7.37 |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
4.08 |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
4.85 |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
436.70 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
116.57 |
| 10 |
Axsome Therapeutics |
12.04 Bn |
11.73 Bn |
176.48 Mn |
204.64 |
| Date | Value |
|---|
| Jun 8, 2026 |
204.64 |
| Jun 5, 2026 |
203.22 |
| Jun 4, 2026 |
201.81 |
| Jun 3, 2026 |
200.36 |
| Jun 2, 2026 |
198.82 |
| Jun 1, 2026 |
197.52 |
| May 29, 2026 |
196.08 |
| May 28, 2026 |
194.55 |
| May 27, 2026 |
193.12 |
| May 26, 2026 |
191.59 |
| May 22, 2026 |
190.04 |
| May 21, 2026 |
188.40 |
| May 20, 2026 |
186.91 |
| May 19, 2026 |
185.60 |
| May 18, 2026 |
184.36 |
| May 15, 2026 |
183.05 |
| May 14, 2026 |
181.73 |
| May 13, 2026 |
180.36 |
| May 12, 2026 |
178.93 |
| May 11, 2026 |
177.78 |
